UMBRALISIB | Small molecule | Mantle cell lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Terminated | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | Mantle cell lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Suspended | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 2.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | polycythemia vera | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 2.0 | Terminated | ClinicalTrials |
UMBRALISIB | Small molecule | diffuse large B-cell lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | follicular lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Terminated | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 2.0 | Suspended | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | rectum cancer | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | Waldenstrom macroglobulinemia | Casein kinase I epsilon inhibitor | 2.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | follicular lymphoma | Casein kinase I epsilon inhibitor | 4.0 | - | DailyMed,FDA |
UMBRALISIB TOSYLATE | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 2.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | rectum cancer | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | Mantle cell lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 1.0 | Terminated | ClinicalTrials |
UMBRALISIB | Small molecule | pancreatic carcinoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | Hodgkins lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | colorectal carcinoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | myelofibrosis | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | pancreatic carcinoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | colorectal carcinoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | myelofibrosis | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | neoplasm of mature B-cells | Casein kinase I epsilon inhibitor | 1.0 | Recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | follicular lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Terminated | ClinicalTrials |
UMBRALISIB | Small molecule | follicular lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | follicular lymphoma | Casein kinase I epsilon inhibitor | 4.0 | - | FDA,DailyMed |
UMBRALISIB TOSYLATE | Small molecule | Mantle cell lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | unspecified peripheral T-cell lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | marginal zone B-cell lymphoma | Casein kinase I epsilon inhibitor | 4.0 | - | FDA |
UMBRALISIB | Small molecule | follicular lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Suspended | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | gastric cancer | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | diffuse large B-cell lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | follicular lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | esophageal cancer | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | marginal zone B-cell lymphoma | Casein kinase I epsilon inhibitor | 4.0 | - | FDA |
UMBRALISIB | Small molecule | diffuse large B-cell lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Terminated | ClinicalTrials |
UMBRALISIB | Small molecule | polycythemia vera | Casein kinase I epsilon inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | gastrointestinal stromal tumor | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
UMBRALISIB | Small molecule | Hodgkins lymphoma | Casein kinase I epsilon inhibitor | 2.0 | Terminated | ClinicalTrials |
UMBRALISIB | Small molecule | esophageal cancer | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | gastrointestinal stromal tumor | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | Hodgkins lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 2.0 | Terminated | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | gastric cancer | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB TOSYLATE | Small molecule | unspecified peripheral T-cell lymphoma | Casein kinase I epsilon inhibitor | 1.0 | Completed | ClinicalTrials |
UMBRALISIB | Small molecule | chronic lymphocytic leukemia | Casein kinase I epsilon inhibitor | 2.0 | Recruiting | ClinicalTrials |